Disparity in outcomes of melanoma adjuvant immunotherapy by demographic profile

BACKGROUND: Randomized comparisons have demonstrated survival benefit of adjuvant immunotherapy in node-positive melanoma patients but have limited power to determine if this benefit persists across various demographic factors. MATERIALS & METHODS: We assessed the impact of demographic factors o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeguchi, Alexandra, Machiorlatti, Michael, Vesely, Sara K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426750/
https://www.ncbi.nlm.nih.gov/pubmed/32821375
http://dx.doi.org/10.2217/mmt-2020-0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426750/
https://www.ncbi.nlm.nih.gov/pubmed/32821375
http://dx.doi.org/10.2217/mmt-2020-0002

Ejemplares similares